PB 41 of 2013
National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 4)
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 24 July 2013
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
1 Name of Instrument
(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 4).
(2) This Instrument may also be cited as PB 41 of 2013.
2 Commencement
This Instrument commences on 1 August 2013.
3 Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
[1] Schedule 1, entry for Alprazolam in the form Tablet 250 micrograms
omit from the column headed “Claimed Price”: 3.12 substitute: 3.32
[2] Schedule 1, entry for Alprazolam in the form Tablet 500 micrograms
omit from the column headed “Claimed Price”: 4.19 substitute: 4.38
[3] Schedule 1, entry for Alprazolam in the form Tablet 1 mg
omit from the column headed “Claimed Price”: 6.26 substitute: 6.47
[4] Schedule 1, entry for Alprazolam in the form Tablet 2 mg
omit from the column headed “Claimed Price”: 8.96 substitute: 9.16
[5] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)
omit from the column headed “Claimed Price”: 4.26 substitute: 5.47
[6] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)
omit from the column headed “Claimed Price”: 6.95 substitute: 8.72
[7] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin
(as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
omit from the column headed “Claimed Price”: 2.50 substitute: 3.90
[8] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin
(as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
omit from the column headed “Claimed Price”: 3.13 substitute: 5.51
[9] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with
125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”: 3.43 substitute: 5.75
[10] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with
125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”: 4.44 substitute: 7.63
[11] Schedule 1, entry for Atenolol
omit from the column headed “Claimed Price”: 3.41 substitute: 3.86
[12] Schedule 1, omit entry for Candesartan
[13] Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Pricing Quantity/Pack Quantity 7]
omit from the column headed “Claimed Price”: 3.04 substitute: 3.50
[14] Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Pricing Quantity/Pack Quantity 21]
omit from the column headed “Claimed Price”: 6.15 substitute: 9.00
[15] Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
omit from the column headed “Claimed Price”: 4.03 substitute: 6.00
[16] Schedule 1, entry for Doxycycline in the form Tablet 50 mg (as hydrochloride)
omit from the column headed “Claimed Price”: 3.42 substitute: 3.76
[17] Schedule 1, omit entry for Gabapentin
[18] Schedule 1, entry for Glimepiride in the form Tablet 1 mg
omit from the column headed “Claimed Price”: 3.30 substitute: 3.58
[19] Schedule 1, entry for Glimepiride in the form Tablet 2 mg
omit from the column headed “Claimed Price”: 4.53 substitute: 4.80
[20] Schedule 1, entry for Glimepiride in the form Tablet 3 mg
omit from the column headed “Claimed Price”: 5.21 substitute: 5.50
[21] Schedule 1, entry for Glimepiride in the form Tablet 4 mg
omit from the column headed “Claimed Price”: 5.94 substitute: 6.23
[22] Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Imdur Durule]
omit from the column headed “Claimed Price”: 6.69 substitute: 7.01
[23] Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Monodur 60 mg]
omit from the column headed “Claimed Price”: 5.97 substitute: 6.20
[24] Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 120 mg (sustained release)
omit from the column headed “Claimed Price”: 12.13 substitute: 12.45
[25] Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
omit from the column headed “Claimed Price”: 5.06 substitute: 5.70
[26] Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
omit from the column headed “Claimed Price”: 7.43 substitute: 8.08
[27] Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Betaloc]
omit from the column headed “Claimed Price”: 5.16 substitute: 5.49
[28] Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Betaloc]
omit from the column headed “Claimed Price”: 5.84 substitute: 6.18
[29] Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
omit from the column headed “Claimed Price”: 11.02 substitute: 11.25
[30] Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
omit from the column headed “Claimed Price”: 11.07 substitute: 11.77
[31] Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
omit from the column headed “Claimed Price”: 14.45 substitute: 14.69
[32] Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
omit from the column headed “Claimed Price”: 17.06 substitute: 17.76
[33] Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
omit from the column headed “Claimed Price”: 21.49 substitute: 21.66
[34] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 20 mg
omit from the column headed “Claimed Price”: 8.78 substitute: 9.46
[35] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 40 mg
omit from the column headed “Claimed Price”: 17.12 substitute: 17.79
[36] Schedule 1, entry for Sucralfate
(a) omit from the column headed “Determined Price”: 11.79 substitute: 15.35
(b) omit from the column headed “Claimed Price”: 13.11 substitute: 17.02
[37] Schedule 1, entry for Telmisartan in the form Tablet 40 mg
omit from the column headed “Claimed Price”: 6.96 substitute: 7.29
[38] Schedule 1, entry for Telmisartan in the form Tablet 80 mg
omit from the column headed “Claimed Price”: 16.98 substitute: 17.30
[39] Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
omit from the column headed “Claimed Price”: 2.85 substitute: 3.24
[40] Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
omit from the column headed “Claimed Price”: 6.41 substitute: 7.11
[41] Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
omit from the column headed “Claimed Price”: 8.19 substitute: 9.03
[42] Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
omit from the column headed “Claimed Price”: 9.67 substitute: 10.63
[43] Schedule 2, omit entry for Candesartan
